Get started
CHIMERIC THERAPEAUTICS LTD.CHIMERIC THERAPEAUTICS LTD.CHIMERIC THERAPEAUTICS LTD.

CHIMERIC THERAPEAUTICS LTD.

No trades
OverviewFinancialsNewsCommunitySeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.26 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0043 USD
Net income (FY)
‪−6.86 M‬ USD
Revenue (FY)
‪2.61 M‬ USD
Shares float
—
Beta (1Y)
3.10

About Chimeric Therapeutics Limited


Sector
Health Technology
Industry
Biotechnology
CEO
Rebecca McQualter
Website
chimerictherapeutics.com
Headquarters
Carlton
Founded
2020
IPO date
Jan 18, 2021
Identifiers
2
ISIN AU0000121576
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.

Check out other big names from the same industry as CHMMF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CHMMF is 0.0010 USD — it has decreased by −96.67% in the past 24 hours. Watch CHIMERIC THERAPEAUTICS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CHIMERIC THERAPEAUTICS LTD. stocks are traded under the ticker CHMMF.
CHMMF reached its all-time high on Nov 30, 2022 with the price of 0.0900 USD, and its all-time low was 0.0010 USD and was reached on Sep 6, 2024. View more price dynamics on CHMMF chart.
See other stocks reaching their highest and lowest prices.
CHMMF stock is ‪2.90 K‬% volatile and has beta coefficient of 3.10. Track CHIMERIC THERAPEAUTICS LTD. stock price on the chart and check out the list of the most volatile stocks — is CHIMERIC THERAPEAUTICS LTD. there?
Yes, you can track CHIMERIC THERAPEAUTICS LTD. financials in yearly and quarterly reports right on TradingView.
CHIMERIC THERAPEAUTICS LTD. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
CHMMF net income for the last half-year is ‪−4.98 M‬ USD, while the previous report showed ‪−1.77 M‬ USD of net income which accounts for −181.63% change. Track more CHIMERIC THERAPEAUTICS LTD. financial stats to get the full picture.
No, CHMMF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHIMERIC THERAPEAUTICS LTD. EBITDA is ‪−11.70 M‬ USD, and current EBITDA margin is −446.65%. See more stats in CHIMERIC THERAPEAUTICS LTD. financial statements.
Like other stocks, CHMMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIC THERAPEAUTICS LTD. stock right from TradingView charts — choose your broker and connect to your account.